J. J. Fernández-Miranda

发表

Mirror image study (10 years of follow-up and 10 of standard pre-treatment) of psychiatric hospitalizations of patients with severe schizophrenia treated in a community-based, case-managed programme.

S. Díaz-Fernández, D. F. Frías-Ortiz, J. J. Fernández-Miranda, 2022, Revista de psiquiatria y salud mental.

Psychosocial and Pharmacological Approaches for Improving Treatment Adherence and Outcomes in People With Severe Schizophrenia: A 10-Year Follow-up.

F. López-Muñoz, S. Díaz-Fernández, J. J. Fernández-Miranda, 2021, Journal of psychiatric practice.

Oral Versus Long-Acting Injectable Antipsychotic Treatment for People With Severe Schizophrenia: A 5-Year Follow-up of Effectiveness.

F. López-Muñoz, S. Díaz-Fernández, J. J. Fernández-Miranda, 2021, The Journal of nervous and mental disease.

Suicide attempts in people with schizophrenia before and after participating in an intensive case managed community program: A 20-year follow-up

D. F. Frías-Ortiz, J. J. Fernández-Miranda, Sylvia Díaz-Fernández, 2020, Psychiatry Research.

Tolerability of effective high doses of paliperidone palmitate in patients with severe resistant schizophrenia

S. Díaz-Fernández, J. J. Fernández-Miranda, J. Fernández-Miranda, 2017, International clinical psychopharmacology.

Long-Acting Injectable Second-Generation Antipsychotics in Seriously Ill Patients with Schizophrenia: Doses, Plasma Levels, and Treatment Outcomes

F. López-Muñoz, S. Díaz-Fernández, J. J. Fernández-Miranda, 2024, Biomedicines.

Paliperidone Palmitate Every Three Months (PP3M) 2-Year Treatment Compliance, Effectiveness and Satisfaction Compared with Paliperidone Palmitate-Monthly (PP1M) in People with Severe Schizophrenia

F. López-Muñoz, D. de Berardis, S. Díaz-Fernández, 2021, Journal of clinical medicine.

Co-occurrence of substance use disorders and other mental disorders in people undergoing specific treatment for any of them in Spain.

S. Díaz-Fernández, J. J. Fernández-Miranda, Francisco Pascual-Pastor, 2021, Adicciones.

Plasmatic Levels and Response to Variable Doses of Monthly Aripiprazole and Three-Month Paliperidone in Patients with Severe Schizophrenia. Treatment Adherence, Effectiveness, Tolerability, and Safety

S. Díaz-Fernández, J. J. Fernández-Miranda, 2023, Neuropsychiatric disease and treatment.

The Use of Second-Generation Antipsychotics in Patients with Severe Schizophrenia in the Real World: The Role of the Route of Administration and Dosage—A 5-Year Follow-Up

F. López-Muñoz, S. Díaz-Fernández, J. J. Fernández-Miranda, 2022, Biomedicines.

Mirror image study (10 years of follow-up and 10 of standard pre-treatment) of psychiatric hospitalizations of patients with severe schizophrenia treated in a community-based, case-managed programme.

S. Díaz-Fernández, D. F. Frías-Ortiz, J. J. Fernández-Miranda, 2019, Revista de psiquiatria y salud mental.